Annals of internal medicine
-
Review
Antibody Response After SARS-CoV-2 Infection and Implications for Immunity : A Rapid Living Review.
The clinical significance of the antibody response after SARS-CoV-2 infection remains unclear. ⋯ Agency for Healthcare Research and Quality. (PROSPERO: CRD42020207098).
-
Comment
In older patients with permanent AF and HF, digoxin and bisoprolol did not differ for QoL at 6 mo.
Kotecha D, Bunting KV, Gill SK, et al. Effect of digoxin vs bisoprolol for heart rate control in atrial fibrillation on patient-reported quality of life: the RATE-AF randomized clinical trial. JAMA. 2020;324:2497-508. 33351042.
-
Observational Study
Development of Severe COVID-19 Adaptive Risk Predictor (SCARP), a Calculator to Predict Severe Disease or Death in Hospitalized Patients With COVID-19.
Predicting the clinical trajectory of individual patients hospitalized with coronavirus disease 2019 (COVID-19) is challenging but necessary to inform clinical care. The majority of COVID-19 prognostic tools use only data present upon admission and do not incorporate changes occurring after admission. ⋯ Hopkins inHealth and COVID-19 Administrative Supplement for the HHS Region 3 Treatment Center from the Office of the Assistant Secretary for Preparedness and Response.
-
The value of frequent, rapid testing to reduce community transmission of SARS-CoV-2 is poorly understood. ⋯ National Institutes of Health.
-
Palmer SC, Tendal B, Mustafa RA, et al. Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials. BMJ. 2021;372:m4573. 33441402.